Post

QurAlis receives authorisation to initiate ALS therapy trial in EU

QurAlis has received clinical trial authorisation (CTA) in the European Union (EU) to initiate a first-in-human, Phase I ANQUR clinical …

BPGbio doses first patients in Phase II GBM therapy trial

BPGbio has dosed the first patients in a Phase II clinical trial of BPM 31510 to treat Glioblastoma Multiforme (GBM), …

ASCO 2023: blockbuster Enhertu demonstrates efficacy across multiple tumour types

At the American Society of Clinical Oncology (ASCO) Annual Meeting, 2-6 June 2023, interim results were presented for the Phase …

FDA open for feedback on GCP draft guidance

The US Food and Drug Administration (FDA) released a draft guidance with updated recommendations for good clinical practices (GCPs). The draft …

IDE clinical trial for artificial cervical disc completes enrollment

Synergy Spine Solutions has enrolled the last patient in its investigational device exemption (IDE) clinical trial. The 1-Level Synergy Disc …